Dow Down0.22% Nasdaq Up0.14%

ARCA biopharma, Inc. (ABIO)

-NasdaqCM
1.35 Up 0.01(0.75%) Aug 22, 3:59PM EDT
|After Hours : 1.39 Up 0.04 (2.96%) Aug 22, 5:08PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development2,928  1,092  2,315  
Selling General and Administrative4,012  3,227  5,046  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (6,940) (4,319) (7,361)
Income from Continuing Operations
Total Other Income/Expenses Net5  2  2,002  
Earnings Before Interest And Taxes(6,935)(4,317)(5,359)
Interest Expense4  3  5  
Income Before Tax(6,939)(4,320)(5,364)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(6,939)(4,320)(5,364)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (6,939) (4,320) (5,364)
Preferred Stock And Other Adjustments(2,026) -   -  
Net Income Applicable To Common Shares (8,965) (4,320) (5,364)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.